4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001553350-26-000111
Chief Medical Officer sold 23,452 shares at an average $6.41 ($150,340)
- Chief Medical Officer acquired 23,452 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Podnos Yale · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +17,974 | $1.87 | $33,611 | 277,501 | D |
| 2026-07-14 | Sale : show line 2 in the form 10b5-1 | −17,974 | $6.43 | $115,555 | 259,527 | D |
| 2026-07-14 | Exercise or conversion : show line 3 in the form 10b5-1 | +5,478 | $2.00 | $10,956 | 265,005 | D |
| 2026-07-14 | Sale : show line 4 in the form 10b5-1 | −5,478 | $6.35 | $34,785 | 259,527 | D |
| Open-market sales · 23,452 sh · avg $6.41 · $150,340 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-14 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | +17,974 | $1.87 | $33,611 | 0 | D |
| 2026-07-14 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | +5,478 | $2.00 | $10,956 | 0 | D |
Loading xslF345X06/ownership.xml…